November 29, 2025 · Form 4 insider transaction
Onyia Jude sold 2,248 shares of Neurocrine Biosciences, Inc. at $152.16 per share, a transaction worth $342.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares withheld by Neurocrine Biosciences, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.